Name: UMIN ID:
Unique ID issued by UMIN | UMIN000021107 |
---|---|
Receipt number | R000024352 |
Scientific Title | A phase I/IIa trial of docetaxel plus ribavirin for reprogramming efficacy in patients with progressive metastatic castration resistant prostate cancer who have previously received docetaxel alone |
Date of disclosure of the study information | 2016/03/01 |
Last modified on | 2016/12/28 21:07:21 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/02/19 17:19:54 | ||
2 | Update | 2016/02/19 17:29:58 | Key inclusion criteria |
|
3 | Update | 2016/02/29 16:10:19 | Recruitment status |
|
4 | Update | 2016/03/09 16:41:11 | Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2016/03/09 16:46:39 | Interventions/Control_1 Interventions/Control_1 |
|
6 | Update | 2016/03/11 09:51:46 | Interventions/Control_1 Interventions/Control_1 |
|
7 | Update | 2016/08/29 18:07:08 | Last follow-up date |
|
8 | Update | 2016/08/29 18:10:32 | Address Address TEL Address Address TEL Name of primary person or sponsor Organization Organization Category of Funding Organization |
|
9 | Update | 2016/10/28 10:00:37 | Institute Institute Department |
|
10 | Update | 2016/12/28 21:07:21 | Recruitment status Last follow-up date Date of closure to data entry |